Invesco’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.85M Sell
133,466
-24,623
-16% -$1.1M ﹤0.01% 2208
2025
Q4
$7.36M Buy
158,089
+68,696
+77% +$3.06M ﹤0.01% 2041
2025
Q3
$3.72M Buy
89,393
+11,253
+14% +$360K ﹤0.01% 2358
2025
Q2
$2.25M Buy
78,140
+8,181
+12% +$253K ﹤0.01% 2531
2025
Q1
$2.35M Sell
69,959
-228,295
-77% -$8.53M ﹤0.01% 2482
2024
Q4
$15.2M Buy
298,254
+42,954
+17% +$2.4M ﹤0.01% 1624
2024
Q3
$13M Buy
255,300
+73,701
+41% +$3.8M ﹤0.01% 1703
2024
Q2
$8.13M Buy
181,599
+4,656
+3% +$215K ﹤0.01% 1923
2024
Q1
$8.28M Buy
176,943
+5,106
+3% +$200K ﹤0.01% 1924
2023
Q4
$6.11M Sell
171,837
-5,536
-3% -$170K ﹤0.01% 2133
2023
Q3
$5.28M Buy
177,373
+139,796
+372% +$2.88M ﹤0.01% 2179
2023
Q2
$677K Sell
37,577
-833
-2% -$16.6K ﹤0.01% 3091
2023
Q1
$617K Buy
38,410
+20,129
+110% +$373K ﹤0.01% 3149
2022
Q4
$335K Sell
18,281
-366
-2% -$6.45K ﹤0.01% 3462
2022
Q3
$366K Sell
18,647
-2,272
-11% -$46.3K ﹤0.01% 3416
2022
Q2
$390K Buy
20,919
+1,576
+8% +$31.5K ﹤0.01% 3456
2022
Q1
$425K Sell
19,343
-170,892
-90% -$3.46M ﹤0.01% 3475
2021
Q4
$5.4M Buy
190,235
+173,734
+1,053% +$4.28M ﹤0.01% 2360
2021
Q3
$347K Buy
16,501
+2,799
+20% +$58.6K ﹤0.01% 3591
2021
Q2
$258K Buy
+13,702
New +$241K ﹤0.01% 3690

Other funds holding CRNX